BeiGene vs Cue Biopharma, .
BeiGene vs Cue Biopharma, ., compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: BeiGene is on 65/100 and Cue Biopharma, . on 62/100.
Where each one leads
BeiGene
- agent readiness: 50/100 against 42/100
- domain rating: 69/100 against 34/100
- funding raised: $358M against $10.0M
Cue Biopharma, .
Leads on none of the measures we hold for both companies.
At a glance
| Measure | BeiGene | Cue Biopharma, . |
|---|---|---|
| What it is | A global oncology company developing and commercializing innovative cancer treatments. | Developing engineered biologics to harness the immune system for disease treatment. |
| Category | Biotech, MedTech, HealthTech, Genomics | Biotech, Drug Discovery, Immunotherapy, Therapeutics |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Biotech |
| Founded | 2010 | 2017 |
| Headquarters | Cambridge, United States | Boston, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | BeiGene | Cue Biopharma, . |
|---|---|---|
| Employees | Not published | 38 |
| Open roles | 99 | Not published |
| Total funding | $358M | $10.0M |
| Latest round | Secondary Offering | Seed |
| Valuation | $15B | Not published |
| LinkedIn followers | Not published | 5,297 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | BeiGene | Cue Biopharma, . |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 65/100 | 62/100 |
| Traction | 40/100 | Not published |
| Team | 40/100 | 60/100 |
| Search visibility | 17/100 | 67/100 |
| Quality | 88/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | D (42/100) |
| Domain ratingLink authority, 0-100 | 69/100 | 34/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | BeiGene | Cue Biopharma, . |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Jquery, Tailwind CSS, Bootstrap | Tailwind CSS |
| Analytics | Not detected | Google Analytics 4 |
BeiGene vs Cue Biopharma, .: common questions
Which is better, BeiGene or Cue Biopharma, .?
On our 0-100 score BeiGene rates higher (65/100 against 62/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do BeiGene and Cue Biopharma, . compare on the numbers?
BeiGene leads on agent readiness (50/100 against 42/100), domain rating (69/100 against 34/100), funding raised ($358M against $10.0M).
Read the full BeiGene review and pricing or the Cue Biopharma, . review and pricing. You can also browse other BeiGene alternatives we track.